病例对照研究
生物
套式病例对照研究
表型
疾病
无症状的
优势比
TLR7型
遗传学
基因
医学
内科学
Toll样受体
受体
先天免疫系统
作者
Chiara Fallerini,Sergio Daga,Stefania Mantovani,Elisa Benetti,Nicola Picchiotti,Daniela Francisci,Francesco Paciosi,Elisabetta Schiaroli,Margherita Baldassarri,Francesca Fava,Maria Palmieri,Serena Ludovisi,Francesco Castelli,Eugenia Quirós-Roldán,Massimo Vaghi,Stefano Rusconi,Matteo Siano,Maria Bandini,Ottavia Spiga,Katia Capitani
出处
期刊:eLife
[eLife Sciences Publications Ltd]
日期:2021-03-02
卷期号:10
被引量:191
摘要
Background: Recently, loss-of-function variants in TLR7 were identified in two families in which COVID-19 segregates like an X-linked recessive disorder environmentally conditioned by SARS-CoV-2. We investigated whether the two families represent the tip of the iceberg of a subset of COVID-19 male patients. Methods: This is a nested case-control study in which we compared male participants with extreme phenotype selected from the Italian GEN-COVID cohort of SARS-CoV-2-infected participants (<60 y, 79 severe cases versus 77 control cases). We applied the LASSO Logistic Regression analysis, considering only rare variants on young male subsets with extreme phenotype, picking up TLR7 as the most important susceptibility gene. Results: Overall, we found TLR7 deleterious variants in 2.1% of severely affected males and in none of the asymptomatic participants. The functional gene expression profile analysis demonstrated a reduction in TLR7-related gene expression in patients compared with controls demonstrating an impairment in type I and II IFN responses. Conclusions: Young males with TLR7 loss-of-function variants and severe COVID-19 represent a subset of male patients contributing to disease susceptibility in up to 2% of severe COVID-19. Funding: Funded by private donors for the Host Genetics Research Project, the Intesa San Paolo for 2020 charity fund, and the Host Genetics Initiative. Clinical trial number: NCT04549831 .
科研通智能强力驱动
Strongly Powered by AbleSci AI